Bei Yu, MD, PhD, currently serves as Vice President of Drug Safety & Pharmacovigilance at Blueprint Medicines, a position held since January 2020. Prior experience includes Senior Medical Director of Drug Safety at Alkermes from March 2018 to December 2019, and Medical Director, Global Safety Officer in Safety, Benefit, and Risk Management at Biogen from July 2014 to March 2018. Bei Yu also held the role of Medical Director, Global Safety Officer for Global Pharmacovigilance & Epidemiology at Genzyme from January 2012 to June 2014.
Sign up to view 0 direct reports
Get started